BIO-key International (NASDAQ:BKYI) Shares Cross Below 200 Day Moving Average – Here’s Why

BIO-key International Inc. (NASDAQ:BKYI) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $5.67 and traded as low as $4.50. BIO-key International shares last traded at $4.60, with a volume of 4,446 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research report on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

BIO-key International Trading Up 4.5%

The firm has a market cap of $4.99 million, a price-to-earnings ratio of -0.66 and a beta of 0.44. The business has a 50 day moving average of $4.72 and a 200 day moving average of $5.67. The company has a quick ratio of 1.13, a current ratio of 1.26 and a debt-to-equity ratio of 0.17.

BIO-key International (NASDAQ:BKYI) last announced its earnings results on Tuesday, March 31st. The technology company reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.70) by $0.51. BIO-key International had a negative net margin of 75.32% and a negative return on equity of 67.43%. The firm had revenue of $1.24 million during the quarter, compared to the consensus estimate of $2.20 million.

Hedge Funds Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC lifted its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is currently owned by hedge funds and other institutional investors.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.